menu
    • menu

    Find Piroxicam-Beta-Cyclodextrin manufacturers, exporters & distributors on PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    5

    API Suppliers

    API Suppliers

    0

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    2

    EU WC

    EU WC

    0

    KDMF

    KDMF

    0

    NDC API

    NDC API

    0

    VMF

    NDC API

    3

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 130

    MARKET PLACE

    2

    API

    0

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    3

    FDF Dossiers

    FDF Dossiers

    0

    FDA Orange Book

    FDA (Orange Book)

    1

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    2

    Listed Dossiers

    Listed Dossiers

    0 DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    0

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    NA

    Finished Drug Prices

    NA

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: Piroxicambeta-cyclodextrin, 121696-62-6, 96684-39-8, Piroxicam mixture with beta-cyclodextrin, Chf 1194, Chf-1194
    Molecular Formula
    C57H83N3O39S
    Molecular Weight
    1466.3  g/mol
    InChI Key
    LBPBSKKEZXLVBQ-ZQOBQRRWSA-N
    Piroxicam-Beta-Cyclodextrin
    1 2D Structure

    Piroxicam-Beta-Cyclodextrin

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol;4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-16,2-benzothiazine-3-carboxamide
    2.1.2 InChI
    InChI=1S/C42H70O35.C15H13N3O4S/c43-1-8-29-15(50)22(57)36(64-8)72-30-9(2-44)66-38(24(59)17(30)52)74-32-11(4-46)68-40(26(61)19(32)54)76-34-13(6-48)70-42(28(63)21(34)56)77-35-14(7-49)69-41(27(62)20(35)55)75-33-12(5-47)67-39(25(60)18(33)53)73-31-10(3-45)65-37(71-29)23(58)16(31)51;1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h8-63H,1-7H2;2-9,19H,1H3,(H,16,17,20)/t8-,9-,10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-;/m1./s1
    2.1.3 InChI Key
    LBPBSKKEZXLVBQ-ZQOBQRRWSA-N
    2.1.4 Canonical SMILES
    CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3.C(C1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(O2)C(C8O)O)CO)CO)CO)CO)CO)CO)O)O)O
    2.1.5 Isomeric SMILES
    CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3.C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)O)CO)CO)CO)CO)CO)CO)O)O)O
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. Chf 1194

    2. Chf-1194

    2.2.2 Depositor-Supplied Synonyms

    1. Piroxicambeta-cyclodextrin

    2. 121696-62-6

    3. 96684-39-8

    4. Piroxicam Mixture With Beta-cyclodextrin

    5. Chf 1194

    6. Chf-1194

    7. Piroxicam-

    8. A-cyclodextrin

    9. Schembl123958

    10. Schembl1649802

    11. Piroxicam-

    12. A-cyclodextrin(x:1)

    13. Dtxsid60242388

    14. Piroxicam-

    15. A-cyclodextrin Complex

    16. Beta-cyclodextrin, Compd. With 4-hydroxy-2-methyl-n-2-pyridinyl-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide

    2.3 Create Date
    2011-12-26
    3 Chemical and Physical Properties
    Molecular Weight 1466.3 g/mol
    Molecular Formula C57H83N3O39S
    Hydrogen Bond Donor Count23
    Hydrogen Bond Acceptor Count41
    Rotatable Bond Count9
    Exact Mass1465.4324410 g/mol
    Monoisotopic Mass1465.4324410 g/mol
    Topological Polar Surface Area662 Ų
    Heavy Atom Count100
    Formal Charge0
    Complexity2090
    Isotope Atom Count0
    Defined Atom Stereocenter Count35
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anti-Inflammatory Agents, Non-Steroidal

    Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)

    Market Place

    Do you need sourcing support? Ask us

    ABOUT THIS PAGE

    Piroxicam-Beta-Cyclodextrin Manufacturers

    A Piroxicam-Beta-Cyclodextrin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Piroxicam-Beta-Cyclodextrin, including repackagers and relabelers. The FDA regulates Piroxicam-Beta-Cyclodextrin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Piroxicam-Beta-Cyclodextrin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Piroxicam-Beta-Cyclodextrin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Piroxicam-Beta-Cyclodextrin Suppliers

    A Piroxicam-Beta-Cyclodextrin supplier is an individual or a company that provides Piroxicam-Beta-Cyclodextrin active pharmaceutical ingredient (API) or Piroxicam-Beta-Cyclodextrin finished formulations upon request. The Piroxicam-Beta-Cyclodextrin suppliers may include Piroxicam-Beta-Cyclodextrin API manufacturers, exporters, distributors and traders.

    click here to find a list of Piroxicam-Beta-Cyclodextrin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Piroxicam-Beta-Cyclodextrin WC

    A Piroxicam-Beta-Cyclodextrin written confirmation (Piroxicam-Beta-Cyclodextrin WC) is an official document issued by a regulatory agency to a Piroxicam-Beta-Cyclodextrin manufacturer, verifying that the manufacturing facility of a Piroxicam-Beta-Cyclodextrin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Piroxicam-Beta-Cyclodextrin APIs or Piroxicam-Beta-Cyclodextrin finished pharmaceutical products to another nation, regulatory agencies frequently require a Piroxicam-Beta-Cyclodextrin WC (written confirmation) as part of the regulatory process.

    click here to find a list of Piroxicam-Beta-Cyclodextrin suppliers with Written Confirmation (WC) on PharmaCompass.

    Piroxicam-Beta-Cyclodextrin GMP

    Piroxicam-Beta-Cyclodextrin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Piroxicam-Beta-Cyclodextrin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Piroxicam-Beta-Cyclodextrin GMP manufacturer or Piroxicam-Beta-Cyclodextrin GMP API supplier for your needs.

    Piroxicam-Beta-Cyclodextrin CoA

    A Piroxicam-Beta-Cyclodextrin CoA (Certificate of Analysis) is a formal document that attests to Piroxicam-Beta-Cyclodextrin's compliance with Piroxicam-Beta-Cyclodextrin specifications and serves as a tool for batch-level quality control.

    Piroxicam-Beta-Cyclodextrin CoA mostly includes findings from lab analyses of a specific batch. For each Piroxicam-Beta-Cyclodextrin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Piroxicam-Beta-Cyclodextrin may be tested according to a variety of international standards, such as European Pharmacopoeia (Piroxicam-Beta-Cyclodextrin EP), Piroxicam-Beta-Cyclodextrin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Piroxicam-Beta-Cyclodextrin USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search